The remaining 10–15% of de novo EGFR mutations comprise a cluster of in-frame insertions in exon 20 found in approximately 2% of all cases of NSCLC [1, 5, 8], as well as other rarer EGFR ‘uncommon’ point mutations [6]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.